Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Rhythm Pharmaceuticals announces $150 million stock offering
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
-
Canaccord Genuity Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $92 at Canaccord Genuity
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $81 at Canaccord Genuity
-
Rhythm Pharmaceuticals (RYTM) PT Lowered to $77 at Canaccord Genuity
-
Rhythm Pharmaceuticals to Report Second Quarter 2024 Financial Results on Tuesday, August 6, 2024
-
Rhythm Pharmaceuticals to Report Second Quarter 2023 Financial Results on Tuesday, August 1, 2023
-
Canaccord Genuity Assumes Rhythm Pharmaceuticals (RYTM) at Buy
-
Rhythm Pharmaceuticals to Present at Canaccord Genuity 42nd Annual Growth Conference
-
Rhythm Pharmaceuticals to Present at Canaccord Genuity 42nd Annual Growth Conference
-
Rhythm Pharmaceuticals to Present at 2021 Canaccord Genuity 41st Annual Growth Conference
-
Rhythm Pharmaceuticals to Present at 2021 Canaccord Genuity 41st Annual Growth Conference
-
Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Rhythm Pharmaceuticals (RYTM) Prices 5M Share Common Offering at $30/Sh
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
-
Rhythm Pharmaceuticals to Present Virtually at Canaccord Genuity 40th Annual Growth Conference
-
Rhythm Pharmaceuticals to Present Virtually at Canaccord Genuity 40th Annual Growth Conference
-
UPDATE: Canaccord Genuity Starts Rhythm Pharmaceuticals (RYTM) at Buy

